Goldman Sachs among backers of China imaging, healthcare IT company to tune of $610M

China's Neusoft will receive $610 million from a variety of investors including Goldman Sachs to fund its medical imaging and healthcare IT ambitions. Other backers include Chinese private equity firm Hony Capital, Neusoft Holdings, Canada Pension Plan Investment Board and Chinese venture firm Frontline BioVentures. The imaging subsidiary Neusoft Medical Systems will receive $440 million, while another subsidiary, Neusoft Xikang Healthcare Technology, will receive $170 million to connect healthcare facilities using big data and cloud computing. Recently, the Chinese government has been making sounds through avenues like the state-controlled media indicating that it would like hospitals to buy more Chinese-made medical equipment, perhaps giving impetus to this investment. The government has a goal of creating 10 med tech breadwinners worth 5 billion yuan ($820 million) apiece by 2020. Story

Suggested Articles

Flatiron has hired a new chief medical officer as it looks to push on under its new parent in the world of electronic health records and real-world data.

Saga Diagnostics has raised 40 million Swedish kronor, or about $4.1 million, to help develop its ultrasensitive cancer liquid biopsy tests.

Terumo will help Orchestra BioMed develop its sirolimus-eluting balloon in both coronary and peripheral cardiovascular interventions.